Amazon has ended a confidential four-year initiative to develop an at-home fertility monitoring device and companion app, according to a CNBC report. The project, codenamed “Encore,” emerged from Amazon’s 2020 acquisition of bluDiagnostics, a Wisconsin-based startup. The technology aimed to analyze saliva samples to measure fertility hormones estradiol and progesterone, with results viewable through a smartphone app. The project was housed within…
Evvy, known for its pioneering work in vaginal microbiome testing, today announced its expansion into treatments with a new line of prescription-grade products for vaginal symptom relief. The launch marks a significant milestone for the female-founded startup, as it’s the first time patients can access Evvy’s prescription products without first taking their vaginal microbiome test. The new product line includes prescription-grade suppositories…
India IVF, a tech-enabled fertility provider, has secured $1.25 million in pre-Series A funding from Tomorrow Capital. This marks the company’s first external investment since its founding in 2014 by Dr. Richika Sahay and Dr. Somendra Shukla, following a decade of profitable operations across five North Indian centers. The investment aims to support India IVF’s expansion across North India, addressing critical gaps…
Fellow Health, a provider of mail-in semen analysis services, has announced it has delivered over 100,000 patient test results since its product launch in 2020. The company reports its testing volume has increased by more than 50% year-to-date from 2023. The company’s mail-in semen analysis service aims to improve access to male fertility testing, addressing a market where 1 in 6 couples…
Parallel Fluidics, a company developing on-demand microfluidic manufacturing solutions with applications in IVF and other life science fields, has secured $7 million in seed funding. The round was led by J2 Ventures with participation from 8VC and Praxis. The company’s technology is already making waves in the fertility sector. Overture Life, a startup focused on simplifying IVF procedures, is utilizing Parallel Fluidics’…
Femasys has announced a strategic partnership with Boston IVF to offer FemaSeed, its FDA-cleared intratubal insemination product, across Boston IVF’s network of nearly 30 fertility centers in the U.S. The collaboration aims to expand access to alternative fertility treatment options before patients progress to more invasive procedures. “We are elated to welcome Boston IVF, a prominent conglomerate in the infertility space, to…
Oura has announced the addition of Fertile Window to its Cycle Insights feature, expanding its women’s health tracking capabilities. The new feature, currently rolling out to iOS users with Android following in coming weeks, uses physiological data to estimate users’ most fertile days. The feature leverages Oura’s existing temperature tracking capabilities, along with other biomarkers including heart rate, heart rate variability, and…
A fictional period tracking app called “RedWave” has emerged as part of a creative campaign to highlight reproductive rights concerns ahead of the 2024 election. The initiative comes from Creatives for Harris, a group of creative professionals organizing with their skills and time to support the Harris-Walz ticket in 2024. The satirical campaign presents the app as one “designed by men, for…
